TLRY
Tilray Brands, Inc. [TLRY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TLRY Stock Summary
Top 10 Correlated ETFs
TLRY
Top 10 Correlated Stocks
TLRY
In the News
TLRY Financial details
Company Rating
Neutral
Market Cap
1.41B
Income
-317.39M
Revenue
743.25M
Book val./share
4.45
Cash/share
0.3
Dividend
-
Dividend %
-
Employees
1.6K
Optionable
No
Shortable
Yes
Earnings
09 Apr 2024
P/E
-0.93
Forward P/E
-
PEG
0.19
P/S
2.23
P/B
0.39
P/C
5.78
P/FCF
-40.34
Quick Ratio
0.89
Current Ratio
1.63
Debt / Equity
0.12
LT Debt / Equity
0.09
-
-
EPS (TTM)
-0.45
EPS next Y
-
EPS next Q
-
EPS this Y
160%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
108.14%
Revenue last 5Y
29.04%
Revenue Q/Q
-2.8%
EPS Q/Q
78.84%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
9.82%
Inst Trans
1.22%
ROA
-33%
ROE
-42%
ROC
-0.35%
Gross Margin
21%
Oper. Margin
-196%
Profit Margin
-202%
Payout
-9%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.5-3.4
52W High
-42.17%
52W Low
+73.5%
RSI
40
Rel Volume
0.58
Avg Volume
28.56M
Volume
16.43M
Perf Week
-8.68%
Perf Month
2.06%
Perf Quarter
1.46%
Perf Half Y
-16.59%
-
-
-
-
Beta
2.459
-
-
Volatility
0.04%, 0.36%
Prev Close
0.87%
Price
1.735
Change
-0.86%
TLRY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-05-31
| Metric | History | 2019-05-31 | 2020-05-31 | 2021-05-31 | 2022-05-31 | 2023-05-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.86 | 3.89 | 1.9 | 1.31 | 1.01 | |
| Net income per share | -0.06 | -0.61 | -1.25 | -0.9 | -2.34 | |
| Operating cash flow per share | -0.2 | -0.96 | -0.17 | -0.37 | 0.01 | |
| Free cash flow per share | -0.95 | -1.91 | -0.31 | -0.44 | -0.02 | |
| Cash per share | 2.07 | 3.57 | 1.81 | 0.86 | 0.73 | |
| Book value per share | 6.19 | 13.01 | 16.54 | 9.14 | 5.37 | |
| Tangible book value per share | 2.44 | 6.15 | 0.1 | 1.09 | 0.56 | |
| Share holders equity per share | 6.19 | 13.01 | 16.54 | 9.14 | 5.37 | |
| Interest debt per share | 1.8 | 3.24 | 3.6 | 1.38 | 0.98 | |
| Market cap | 10.46B | 1.37B | 4.58B | 2.16B | 1.03B | |
| Enterprise value | 10.41B | 1.31B | 5.03B | 2.37B | 1.42B | |
| P/E ratio | -857.73 | -22.43 | -13.62 | -4.98 | -0.72 | |
| Price to sales ratio | 59.68 | 3.5 | 8.92 | 3.44 | 1.65 | |
| POCF ratio | -254.5 | -14.2 | -102.35 | -12.19 | 130.54 | |
| PFCF ratio | -54.1 | -7.13 | -54.75 | -10.22 | -80.04 | |
| P/B Ratio | 8.3 | 1.05 | 1.03 | 0.49 | 0.31 | |
| PTB ratio | 8.3 | 1.05 | 1.03 | 0.49 | 0.31 | |
| EV to sales | 59.42 | 3.35 | 9.8 | 3.77 | 2.26 | |
| Enterprise value over EBITDA | 725.4 | 19.52 | 166.06 | 8.82 | -12.32 | |
| EV to operating cash flow | -253.39 | -13.59 | -112.42 | -13.36 | 179.05 | |
| EV to free cash flow | -53.87 | -6.83 | -60.14 | -11.21 | -109.78 | |
| Earnings yield | 0 | -0.04 | -0.07 | -0.2 | -1.4 | |
| Free cash flow yield | -0.02 | -0.14 | -0.02 | -0.1 | -0.01 | |
| Debt to equity | 0.29 | 0.23 | 0.21 | 0.14 | 0.18 | |
| Debt to assets | 0.2 | 0.17 | 0.16 | 0.11 | 0.14 | |
| Net debt to EBITDA | -3.2 | -0.87 | 14.87 | 0.77 | -3.34 | |
| Current ratio | 5.64 | 5.3 | 2.2 | 2.87 | 1.79 | |
| Interest coverage | -0.45 | 2.08 | -0.16 | 3.86 | -100.81 | |
| Income quality | 3.37 | 1.58 | 0.13 | 0.41 | -0.01 | |
| Dividend Yield | 0 | 0 | 0 | 3.46 | 0.08 | |
| Payout ratio | 0 | -0.08 | 0 | -17.24 | -0.06 | |
| Sales general and administrative to revenue | 0.4 | 0.23 | 0.22 | 0.26 | 0.26 | |
| Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.43 | 0.39 | 0.74 | 0.72 | 0.69 | |
| Capex to operating cash flow | 3.7 | 0.99 | 0.87 | 0.19 | -2.63 | |
| Capex to revenue | -0.87 | -0.24 | -0.08 | -0.05 | -0.03 | |
| Capex to depreciation | -8.98 | -2.69 | -0.57 | -0.22 | -0.16 | |
| Stock based compensation to revenue | 0.11 | 0.04 | 0.03 | 0.06 | 0.06 | |
| Graham number | 2.89 | 13.33 | 21.54 | 13.62 | 16.79 | |
| ROIC | 0 | 0.03 | 0 | 0.03 | -0.35 | |
| Return on tangible assets | -0.01 | -0.06 | -0.21 | -0.28 | -1.09 | |
| Graham Net | -0.1 | 0.16 | -3.25 | -0.83 | -0.59 | |
| Working capital | 474.71M | 528.39M | 482.37M | 523.16M | 340.05M | |
| Tangible asset value | 496.12M | 618.12M | 26.6M | 522.19M | 347.32M | |
| Net current asset value | 53.5M | 175.33M | -676.44M | -204.83M | -204.29M | |
| Invested capital | 0.29 | 0.23 | 0.21 | 0.14 | 0.18 | |
| Average receivables | 38.96M | 57.37M | 70.28M | 92.54M | 90.75M | |
| Average payables | 51.32M | 94.17M | 83.92M | 63.16M | 69.71M | |
| Average inventory | 42.41M | 129.1M | 223.49M | 250.98M | 223.04M | |
| Days sales outstanding | 133.23 | 47.39 | 63.88 | 55.34 | 50.19 | |
| Days payables outstanding | 238.86 | 158.68 | 54.02 | 48.95 | 53.83 | |
| Days of inventory on hand | 206.62 | 274.58 | 240.05 | 175.19 | 152.45 | |
| Receivables turnover | 2.74 | 7.7 | 5.71 | 6.6 | 7.27 | |
| Payables turnover | 1.53 | 2.3 | 6.76 | 7.46 | 6.78 | |
| Inventory turnover | 1.77 | 1.33 | 1.52 | 2.08 | 2.39 | |
| ROE | -0.01 | -0.05 | -0.08 | -0.1 | -0.44 | |
| Capex per share | -0.75 | -0.95 | -0.14 | -0.07 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2024-02-29 for Q3
| Metric | History | 2023-02-28 | 2023-05-31 | 2023-08-31 | 2023-11-30 | 2024-02-29 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.24 | 0.28 | 0.26 | 0.27 | 0.25 | |
| Net income per share | -1.94 | -0.18 | -0.08 | -0.07 | -0.12 | |
| Operating cash flow per share | -0.03 | 0.07 | -0.02 | -0.04 | -0.02 | |
| Free cash flow per share | -0.03 | 0.05 | -0.03 | -0.05 | -0.03 | |
| Cash per share | 0.66 | 0.68 | 0.67 | 0.36 | 0.3 | |
| Book value per share | 5.53 | 5.05 | 4.89 | 4.61 | 4.45 | |
| Tangible book value per share | 0.66 | 0.53 | 0.61 | 0.59 | 0.53 | |
| Share holders equity per share | 5.53 | 5.05 | 4.89 | 4.61 | 4.45 | |
| Interest debt per share | 0.98 | 0.91 | 0.83 | 0.74 | 0.55 | |
| Market cap | 1.74B | 1.1B | 2.05B | 1.32B | 1.31B | |
| Enterprise value | 2.18B | 1.48B | 2.43B | 1.71B | 1.64B | |
| P/E ratio | -0.36 | -2.29 | -9.16 | -6.75 | -3.52 | |
| Price to sales ratio | 11.96 | 5.95 | 11.56 | 6.83 | 6.93 | |
| POCF ratio | -93.49 | 25.15 | -129.15 | -43.5 | -81.18 | |
| PFCF ratio | -89.38 | 35.16 | -102.33 | -36.47 | -50.64 | |
| P/B Ratio | 0.51 | 0.33 | 0.61 | 0.39 | 0.39 | |
| PTB ratio | 0.51 | 0.33 | 0.61 | 0.39 | 0.39 | |
| EV to sales | 14.98 | 8.04 | 13.74 | 8.82 | 8.71 | |
| Enterprise value over EBITDA | -40.98 | -213.18 | -318.58 | -416.15 | -2.97K | |
| EV to operating cash flow | -117.04 | 33.95 | -153.46 | -56.19 | -102.04 | |
| EV to free cash flow | -111.89 | 47.45 | -121.59 | -47.11 | -63.65 | |
| Earnings yield | -0.69 | -0.11 | -0.03 | -0.04 | -0.07 | |
| Free cash flow yield | -0.01 | 0.03 | -0.01 | -0.03 | -0.02 | |
| Debt to equity | 0.18 | 0.18 | 0.17 | 0.16 | 0.12 | |
| Debt to assets | 0.14 | 0.14 | 0.13 | 0.12 | 0.1 | |
| Net debt to EBITDA | -8.25 | -55.24 | -50.48 | -94.01 | -607.55 | |
| Current ratio | 1.61 | 1.79 | 1.54 | 1.63 | 1.92 | |
| Interest coverage | -1.16K | -17.9 | -3.49 | -4.84 | -3.92 | |
| Income quality | 0.02 | -0.36 | 0.28 | 0.66 | 0.17 | |
| Dividend Yield | 0 | 0.12 | 0 | 0 | 0 | |
| Payout ratio | 0 | -1.07 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.27 | 0.26 | 0.23 | 0.22 | 0.21 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.69 | 0.69 | 0.68 | 0.68 | 0.7 | |
| Capex to operating cash flow | 0.05 | -0.28 | 0.26 | 0.19 | 0.6 | |
| Capex to revenue | -0.01 | -0.07 | -0.02 | -0.03 | -0.05 | |
| Capex to depreciation | -0.03 | -0.43 | -0.13 | -0.19 | -0.3 | |
| Stock based compensation to revenue | 0.07 | 0.05 | 0.05 | 0.04 | 0.04 | |
| Graham number | 15.55 | 4.55 | 2.98 | 2.64 | 3.51 | |
| ROIC | -0.3 | -0.02 | -0.01 | -0.01 | -0.01 | |
| Return on tangible assets | -0.87 | -0.09 | -0.04 | -0.04 | -0.07 | |
| Graham Net | -0.65 | -0.55 | -0.52 | -0.66 | -0.6 | |
| Working capital | 288.83M | 340.05M | 291.98M | 247.04M | 302.11M | |
| Tangible asset value | 406.75M | 347.32M | 424.32M | 430.22M | 403.3M | |
| Net current asset value | -210.62M | -204.29M | -171.44M | -295.18M | -238.6M | |
| Invested capital | 0.18 | 0.18 | 0.17 | 0.16 | 0.12 | |
| Average receivables | 84.02M | 82.28M | 84.15M | 86.34M | 90.07M | |
| Average payables | 71.4M | 68.94M | 74.9M | 83.67M | 89.26M | |
| Average inventory | 221.87M | 201.68M | 216.31M | 242.39M | 248.42M | |
| Days sales outstanding | 48.43 | 42.13 | 41.75 | 42.08 | 42.79 | |
| Days payables outstanding | 38.37 | 54.46 | 53.54 | 54.34 | 50.56 | |
| Days of inventory on hand | 116.04 | 154.24 | 157.34 | 155.39 | 136.9 | |
| Receivables turnover | 1.86 | 2.14 | 2.16 | 2.14 | 2.1 | |
| Payables turnover | 2.35 | 1.65 | 1.68 | 1.66 | 1.78 | |
| Inventory turnover | 0.78 | 0.58 | 0.57 | 0.58 | 0.66 | |
| ROE | -0.35 | -0.04 | -0.02 | -0.01 | -0.03 | |
| Capex per share | 0 | -0.02 | -0.01 | -0.01 | -0.01 |
TLRY Frequently Asked Questions
What is Tilray Brands, Inc. stock symbol ?
Tilray Brands, Inc. is a CA stock , located in Leamington of On and trading under the symbol TLRY
What is Tilray Brands, Inc. stock quote today ?
Tilray Brands, Inc. stock price is $1.735 today.
Is Tilray Brands, Inc. stock public?
Yes, Tilray Brands, Inc. is a publicly traded company.
Company Profile
- Volume Average 28.56M
- Market Capitalization 1.41B
- Employee 1.6K
- CEO Mr. Irwin David Simon
- Headquarters Leamington,ON,CA
- IPO Date 2018-07-19
-
Website
https://www.tilray.com 
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
